1) 1,8-dihydroxyanthraquinone
1,8-二羟蒽醌
1.
Inhibitory effect and kinetic analysis of 1,8-dihydroxyanthraquinone on recombinant human protein kinase CK2 holoenzyme;
1,8-二羟蒽醌对重组人蛋白激酶CK2全酶的抑制作用及其动力学分析
2) 1,8-dihydroxy-9,10-anthraquinone
1,8-二羟基-9,10-蒽醌
1.
Methods Target compounds were synthesized from 1,8-dihydroxy-9,10-anthraquinone via 5 steps including protecting, nitration, methyl mercaptoacetate substitution, intramolecular Aldol reaction and deprotecting.
方法以1,8-二羟基-9,10-蒽醌为原料,经过保护、硝化、巯代、环合和脱保护5步反应,合成目标分子。
2.
Methods Target molecule-demethyl bryoanthrathiophene was synthesized in 5 steps using 1,8-dihydroxy-9,10-anthraquinone as the starting material, 5,7-dihydroxy-1-carboxyl-6-oxo-6H-anthra thiophene as the key intermediate and decarboxylization as the key step.
方法以1,8-二羟基-9,10-蒽醌为原料,5,7-二羟基-1-羧基-6-酮-6H-蒽[1,9-bc]噻吩为关键中间体,脱羧反应为关键步骤,经5步反应合成目标分子。
3) 1,8-dihydroxyanthraquinone
1,8-二羟基蒽醌
1.
AIM: To investigate the transepithelial transport of the six free anthraquinones 1,8-dihydroxyanthraquinone (DQ),chrysophanol (CP),emodin (EN),rhein (RN),aloe-emodin (AE) and citreorosein (CN) in the human intestinal Caco-2 cell monolayer model.
目的:研究1,8-二羟基蒽醌(1,8-dihydroxyanthraquinone,DQ)、大黄酚(chrysophanol,CP)、大黄素(emodin,EN)、大黄酸(rhein,RN)、芦荟大黄素(aloe-emodin,AE)和ω-羟基大黄素(citreorosein,CN)在人肠Caco-2细胞单层模型的转运。
2.
Methods The determination was based on the reaction between magnesium ion and 1,8-dihydroxyanthraquinone at 505 nm.
结果1,8-二羟基蒽醌与镁离子形成配位化合物在505nm处的表观百分吸收系数为(513。
4) 4,5'-Dinitrocyrazine
1,8-二羟基-4,5-二硝基蒽醌
5) 1,8-Diamino-4,5-dihydroxyanthraquinone
1,8-二氨基-4,5-二羟基蒽醌
6) 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid
1,8-二羟基-3-羧基蒽醌
补充资料：1,2,5,8-四羟蒽醌
分子式：
CAS号：
性质：又称1,2,5,8-四羟蒽醌。红色针状晶体，具绿色金属光泽。极微溶于多种溶剂，不溶于水。在碱性水溶液中呈红紫色，醋酸溶液中为黄色，硫酸中为蓝紫色。测定铍、镁、钙、铝、硼等的试剂。
CAS号：
性质：又称1,2,5,8-四羟蒽醌。红色针状晶体，具绿色金属光泽。极微溶于多种溶剂，不溶于水。在碱性水溶液中呈红紫色，醋酸溶液中为黄色，硫酸中为蓝紫色。测定铍、镁、钙、铝、硼等的试剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条